Meetings: Molecular and Clinical Genetics Panel of Medical Devices Advisory Committee
Document ID: FDA-2011-N-0066-0001
Comments
Total: 15
-
Howard C Wetsman - Comment
Posted : 02/18/2011 ID ：FDA-2011-N-0066-0002 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Precision Quality DNA - Comment
Posted : 02/18/2011 ID ：FDA-2011-N-0066-0003 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Yale School of Medicine - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0004 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Jeffrey Michael Yunes - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0005 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
American Medical Association (AMA) - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0006 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
BJ Mitchell - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0007 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
KEVIN DAVIES - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0008 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Council for Responsible Genetics (CRG) - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0009 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Mark Gibbs - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0010 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
American Clinical Laboratory Association (ACLA) - Comment
Posted : 03/03/2011 ID ：FDA-2011-N-0066-0011 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
College of American Pathologists - Comment
Posted : 03/07/2011 ID ：FDA-2011-N-0066-0012 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Interleukin Genetics, Inc. - Comment
Posted : 03/07/2011 ID ：FDA-2011-N-0066-0013 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Genetics and Public Policy Center, Johns Hopkins U. - Comment
Posted : 03/07/2011 ID ：FDA-2011-N-0066-0014 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Pendergast Consulting - Comment
Posted : 03/07/2011 ID ：FDA-2011-N-0066-0015 Agency : FDA -
Mar 01,2011 11:59 PM ET
-
Interleukin Genetics, Inc. - Comment
Posted : 03/07/2011 ID ：FDA-2011-N-0066-0016 Agency : FDA -
Mar 01,2011 11:59 PM ET